From South China Morning Post:
Precision NanoSystems Inc. has increased its revenue almost 800 per cent since it was founded six years ago by carving out a niche in the biotechnology industry.
Instead of making its own drugs, the small Vancouver-based tech company is focused on a faster way to create nanoparticles, which improve the precision of delivering medicine into the human body.
Tim Leaver, Precision’s head of product development, said the company decided early in its evolution that it didn’t want to make its own drugs because there was more opportunity in participating with the industry as a whole, instead of battling for market share in what is an extremely competitive industry.
“We wanted to make our technology accessible to others.”
While other biotech firms were competing to make the next great nanomedicine, Precision developed a platform to help researchers create nanoparticles faster and easier.